S'abonner

Similar wear rates of 1st and 2nd generation highly cross-linked polyethylene in primary total hip arthroplasty in patients less than 30 years of age: A minimum 5-year follow-up - 01/02/25

Doi : 10.1016/j.otsr.2025.104178 
Jung Shin Kim a, b, Min Uk Do a, Jung Bum Han a, Sang-Min Lee a, Nam Hoon Moon c, Kuen Tak Suh a, d, Won Chul Shin a,
a Department of Orthopaedic Surgery, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan, Gyeongsangnam-do 626-770, 50612, Republic of Korea 
b Department of Orthopaedic Surgery, Bumin Hospital, 59 Mandeok-daero, Buk-gu, Busan, 46555, Republic of Korea 
c Department of Orthopaedic Surgery, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, Republic of Korea 
d Department of Orthopaedic Surgery, Sehung Hospital, 805 Jungang-daero, Busanjin-gu, Busan, 614842, Republic of Korea 

Corresponding author.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Saturday 01 February 2025

Abstract

Background

Younger patients who undergo total hip arthroplasty (THA) often exhibit higher activity and functionality. After the 1 st generation highly cross-linked polyethylene liners (HXLPE), there was advancement with the development of the 2nd generation Vitamin E-infused highly cross-linked polyethylene (VEPE) for polyethylene liners. However, there is limited research comparing these advancements, especially in younger patients. Therefore we did a retrospective comparative study aiming to determine: 1) the wear rate, 2) survivorships of the 1 st and 2nd generations of HXLPE in patients aged <30 years who underwent THA.

Hypothesis

There is no difference between first and second generation of highly cross-linked polyethylene regarding lower linear and volumetric wear rates.

Methods

From 2008–2019, we selected 121 patients, 150 hips of ceramic-polyethylene articulation THA in patients aged <30 years at least 5 years of follow-up. These patients were divided into two groups: 80 hips for 1 st generation HXLPE and 70 hips for 2nd generation VEPE. Both groups had no significant difference regarding age, gender, BMI, and the indication for THA. We compared the wear rate of polyethylene in both groups using PolyWare 7 software and assessed the 5-year THA survival rate.

Results

In both groups, there was no significant difference in linear and volumetric wear, as measured using PolyWare 7 software. Linear wear rate was 0.0365 ± 0.0187 mm/yr in the 1 st generation HXLPE and 0.0351 ± 0.0171 mm/yr in the 2nd generation VEPE groups. Volumetric wear rate was 20.848 ± 11.319 mm3/yr in the 1 st generation HXLPE and 18.679 ± 7.933 mm3/yr in the 2nd generation VEPE groups. The overall 5-year survival rate post-surgery was 98.7%; no significant difference in the survival rates between the 1 st and 2nd generation groups (98.8 and 98.6% for the 1 st and 2nd generation groups).

Conclusion

In young patients, there was no significant difference in the wear rates between the 1 st generation HXLPE and 2nd generation VEPE when using ceramic-polyethylene bearing surfaces. Based on the analysis of complications, survival rates, and functional scores post-surgery, the results of THA using ceramic-any HXLPE articulation were satisfactory in patients aged <30 years.

Level of evidence

III; Case-control study

Le texte complet de cet article est disponible en PDF.

Keywords : Total hip arthroplasty, Highly cross-linked polyethylene, Ceramic-polyethylene articulation, Bearing surfaces


Plan


© 2025  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.